<DOC>
	<DOCNO>NCT00082121</DOCNO>
	<brief_summary>The purpose study determine study drug ( TP10 ) , block complement release , reduce side effect complement inflammation chest pain heart attack take safely woman undergo cardiopulmonary bypass surgery .</brief_summary>
	<brief_title>Safety Efficacy TP10 , Complement Inhibitor , Adult Women Undergoing Cardiopulmonary Bypass Surgery</brief_title>
	<detailed_description>During cardiac surgery , substance call “ complement ” release body . This complement cause inflammation , lead side effect chest pain , heart attack , heart failure . The purpose study determine study drug ( TP10 ) , block complement release , reduce side event take safely woman .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Complement System Proteins</mesh_term>
	<criteria>Female To undergo highrisk cardiac surgery cardiopulmonary bypass pump ( CPB ) CABG alone valve surgery Acute myocardial infarction ( heart attack ) within 3 day enter study Conditions may interfere interpretation electrocardiogram data History immune deficiency syndrome Planned supplemental cardiac surgery surgery Pregnancy lactation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>cardiac bypass</keyword>
	<keyword>CABG</keyword>
	<keyword>complement activation</keyword>
</DOC>